BIDMC scientist John Rinn named one of the 'Brilliant 10' by Popular Science magazine

October 15, 2009

BOSTON -- Beth Israel Deaconess Medical Center (BIDMC) geneticist John Rinn, PhD, whose research has helped uncover a new class of RNA, has been named to this year's "Brilliant 10" list of top young scientists by Popular Science magazine. The list appears in the magazine's November issue, which is on newsstands today.

Rinn is a member of BIDMC's Department of Pathology and is an Assistant Professor of Pathology at Harvard Medical School.

Dubbed "The Rule Shredder" by the magazine, Rinn has a long history of bucking convention - and upending the way biologists think about the human genome. In 2003, as a graduate student at Yale, Rinn first discovered large intervening non-coding RNA, or lincRNA, a new class of molecule that has been shown to play a leading role in the human genome - though until recently had been dismissed as "genomic junk" despite Rinn's assertions to the contrary.

As Popular Science notes, "[Rinn] silenced his critics in 2007 when he showed that one of the [lincRNA molecules] serves a vital function in human cells. He dubbed it HOTAIR, a wry nod to the fact that so many scientists thought his field of research was full of it. The molecule delivers proteins to a crucial cluster of genes and helps regulate immune response, cancer growth and fat- and stem-cell production, among other things."

"John Rinn is revolutionizing the way we think about the human genome," says BIDMC Chief of Pathology Jeffrey Saffitz, MD, PhD. "The potential implications for understanding disease are profound. We are particularly pleased that John has chosen to work in a pathology department, where scientific advances can be translated to improve patient care."

Earlier this year, in the scientific journal Nature, Rinn described his discovery of more than 1,000 functional lincRNA molecules in mammals. Using a novel means of analysis, he and his colleagues uncovered a set of genetic elements that could one day lead to new avenues for developing therapeutics, particularly in cancers.

Last month, Rinn's "outside-the-box" thinking was further rewarded when he received a grant from the National Institutes of Health (NIH) as part of their New Innovator Awards, one of three new programs designed to encourage investigators to explore bold ideas that have the potential to catapult fields forward and speed the translation of research into improved health. Rinn's $2.6 million grant will further his investigations into lincRNAs and their potential to help stem disease.

As Rinn notes, "If we can solve the code of how each lincRNA knows what part of the genome to regulate, we might be able to exploit this mechanism to engineer lincRNAs that 'fix' a damaged cancer genome by targeting and silencing overactive cancer cells, thereby restoring the genome back to its proper identity."
-end-
Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School and consistently ranks in the top four in National Institutes of Health funding among independent hospitals nationwide. BIDMC is a clinical partner of the Joslin Diabetes Center and a research partner of the Harvard/Dana-Farber Cancer Center. BIDMC is the official hospital of the Boston Red Sox. For more information visit www.bidmc.org.

Beth Israel Deaconess Medical Center

Related Genome Articles from Brightsurf:

Genome evolution goes digital
Dr. Alan Herbert from InsideOutBio describes ground-breaking research in a paper published online by Royal Society Open Science.

Breakthrough in genome visualization
Kadir Dede and Dr. Enno Ohlebusch at Ulm University in Germany have devised a method for constructing pan-genome subgraphs at different granularities without having to wait hours and days on end for the software to process the entire genome.

Sturgeon genome sequenced
Sturgeons lived on earth already 300 million years ago and yet their external appearance seems to have undergone very little change.

A sea monster's genome
The giant squid is an elusive giant, but its secrets are about to be revealed.

Deciphering the walnut genome
New research could provide a major boost to the state's growing $1.6 billion walnut industry by making it easier to breed walnut trees better equipped to combat the soil-borne pathogens that now plague many of California's 4,800 growers.

Illuminating the genome
Development of a new molecular visualisation method, RNA-guided endonuclease -- in situ labelling (RGEN-ISL) for the CRISPR/Cas9-mediated labelling of genomic sequences in nuclei and chromosomes.

A genome under influence
References form the basis of our comprehension of the world: they enable us to measure the height of our children or the efficiency of a drug.

How a virus destabilizes the genome
New insights into how Kaposi's sarcoma-associated herpesvirus (KSHV) induces genome instability and promotes cell proliferation could lead to the development of novel antiviral therapies for KSHV-associated cancers, according to a study published Sept.

Better genome editing
Reich Group researchers develop a more efficient and precise method of in-cell genome editing.

Unlocking the genome
A team led by Prof. Stein Aerts (VIB-KU Leuven) uncovers how access to relevant DNA regions is orchestrated in epithelial cells.

Read More: Genome News and Genome Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.